Especial considerations for neurotoxicological research

Comparative and correlative neuroanatomy for the toxicologic pathologist

Xenobiotic-induced neuroanatomic alterations are always regarded as adverse and are commonly used to define reference doses to manage neurotoxic risk. Thus, the neuropathologist plays an essential role in evaluating potential neurotoxicants. The pathologist must be able to recognize the morphologic differences that exist among species, strains, and ages or between genders (comparative neuroanatomy) and to grasp the impact of structural damage on neural function (correlative neuroanatomy). Brain anatomy and function may be used to group the mammals used in neurotoxicity bioassays into 3 classes: rodent, carnivore, and primate. Neural function may or may not be affected by the structural divergence. Rodents are preferred for neurotoxicity assays because their reduced body size allows optimal perfusion at little cost and their smaller brain size permits screening of multiple regions using few sections. However, care must be exercised when interpreting rodent neuropathology data because the rodent paleocortex does not recapitulate the sophisticated neocortical circuitry and functions of carnivores and primates. Knowledge of the neuroanatomic variations that exist among test species assists the neuropathologist in defining the relevance of structural alterations, the potential clinical sequelae of such findings, and the possible significance of similar changes in humans.

Biochemical markers of neurotoxicity: research strategies and epidemiological applications

A great deal of attention has been given in the past few years to the development and validation of biomarkers for non-cancer endpoints, to be used in human epidemiological studies. In this research, as they apply to the field of neurotoxicology, will be discussed. As biomarkers are often divided into indicators of exposure, effect and susceptibility, one example for each of these classes is presented. Measurements of hemoglobin adducts were developed as a way to monitor exposure to acrylamide (a peripheral neurotoxicant) in animals as well as humans, and have been successfully applied in a field study in occupationally exposed workers. Activity of monoamine oxidase B (MAO-B) in platelets was found to be inversely correlated with the levels of exposure to styrene, suggesting that this biochemical measurement may be a useful effect-related biomarker, though additional studies are needed to understand the mechanistic implications of these findings. Serum paraoxonase activity has been shown in animals to modulate the toxicity of organophosphorus insecticides. Studies in humans have lead to the identification of a genetic polymorphism for this enzyme and to define its underlying molecular basis. Epidemiological studies are needed to determine the relevance of this polymorphism in determining susceptibility to organophosphate toxicity.

Methodology in neurotoxicology--activities within the World Health Organization and International Programme on Chemical Safety

For many years, the potential deleterious effects of environmental factors on the human nervous system has been examined by several programmes within the World Health Organization (WHO). This presentation will concentrate on the development of methodology to determine the health risks from chemical exposures both in the work place, as well as, the general environment. IPCS as a scientifically based cooperative programme of the United Nations Environment Programme, International Labour Organisation, and WHO, has as one of its goals the development and use of methods to assess human health and environmental risks from chemicals. In this presentation, emphasis will be given to the development by IPCS of an integrated multidisciplinary approach for assessing the neurotoxic potential of chemicals and the risks to human health. The complexity of the nervous system and the variety of effects caused by chemicals will demand several tests in a multidisciplinary approach if the neurotoxic risk of any chemical is to be adequately characterized. Efforts by IPCS to evaluate the use of in vitro and neurobehavioural tests for screening purposes will be discussed as will the roles played by pathology, biochemistry, and neurophysiology in the characterization of neurotoxic risk. Finally, the WHO neurobehavioural core battery developed within the Occupational Health Programme will be described briefly.

Quantitative enzyme histochemistry of rat foetal brain and trigeminal ganglion

The increasing concern and the efforts in determining neurological effects in offsprings resulting from maternal exposure to xenobiotics are faced with several difficulties in monitoring damage to the central nervous system. In this paper, the efficiency of several enzyme histochemical reactions for analysing the forebrain and the trigeminal ganglia of rat foetuses are reported. Brains of 20-day-old Sprague-Dawley rat foetuses were frozen and analysed for 18 enzymes that had previously been used to monitor initial injury caused by toxic compounds in liver and other organs. Eight enzymes appeared suitable as histochemical markers for the functional integrity of different areas in brain and ganglia of rats exposed to xenobiotics. They were lactate, malate, glycerophosphate (NAD-linked), succinate, aldehyde and glucose 6-phosphate dehydrogenases, alpha-glycerophosphate-menadione oxidoreductase and cytochrome c oxidase. The activities of the enzymes were determined by microphotometry and the arrangement of absorbances of the enzyme final reaction products into appropriate analytical tables is proposed as an efficient procedure for data analysis.